1st Quarter - Report

ARENTFOX SCHIFF LLP for ORGANOGENESIS INC.

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Medical device excise tax generally H.R. 195 (Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes), Section 4001 regarding extension of medical device excise tax

LobbyistCovered position, as disclosed
PHILIP ENGLISH —
DAN RENBERG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 195 (115th)

Health Issues HCR

Food and Drug Administration policy on chronic wound healing products Food and Drug Administration user fee policy Federal research funding for wound healing products

LobbyistCovered position, as disclosed
JAMES RAVITZ —
DAN RENBERG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare reimbursement policy for chronic wound healing products H.R. 1625 (Consolidated Appropriations Act, 2018), Section 1301, regarding Medicare reimbursement policy for wound healing products

LobbyistCovered position, as disclosed
DAN RENBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1625 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.